Updated Guidelines on the Application for License to Operate of Health Product Establishments with the Food and Drug Administration; (15 page(s), in English)

Draft Commission Implementing Regulation approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (6 page(s), in English), (4 page(s), in English)

Proposed amendments to the Korean Pharmacopeia; (3 page(s), in Korean), (212 page(s), in Korean), (439 page(s), in Korean), (62 page(s), in Korean)